GI & Endoscopy

Evoke Pharma submitted a new drug application to the FDA for its acute and recurrent diabetic gastroparesis nasal spray Gimoti. The spray relieves symptoms in adult women.

There have been five recent deaths in association with liquid-filled intragastic balloons for the treatment of obesity, bringing the total number of deaths to 12 since 2016, CNN reports.

Salix Pharmaceuticals presented data from its phase 3 trial of Rifaximin, finding the drug treated irritable bowel syndrome with diarrhea patients effectively but with a small number of adverse events.

William Salyers, Jr., MD, is a gastroenterologist at KU Wichita (Kan.) Gastroenterology.

Motus GI highlighted data showing its Pure-Vu System lowered repeat colonoscopy cost and colorectal cancer incidence rate because of the system's ability to improve colon prep.

Pentax Medical launched its C2 CryoBalloon Ablation System at Digestive Disease Week, June 2 to June 5 in Washington, D.C.

High-performing gastroenterologists given video-based machine-learning models can identify 20 percent more polyps than when using traditional methods, according to a study presented at Digestive Disease Week, June 2 to June 5 in Washington, D.C, Medscape reports.

The American Gastroenterological Association issued a statement in support of the American Cancer Society's updated colorectal cancer guideline, suggesting individuals begin getting screened for CRC at 45. 

Colorectal cancer treatment costs twice as much in the U.S. as it does in Canada, although the survival rate is almost identical, according to a study presented at the 2018 American Society of Clinical Oncology Annual Meeting in Chicago, detailed…

Here are the five most popular gastroenterology and endoscopy stories for the week of May 28 to June 3, 2018.